Covered recipient · General Payments record
JOHN D SPRANDIO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$6,546.34
- Reported across 275 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,995.26 | 71 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $764.07 | 21 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $128.30 | 6 |
| Acerta Pharma LLC | $118.73 | 5 |
| PFIZER INC. | $116.32 | 6 |
| E.R. Squibb & Sons, L.L.C. | $96.15 | 2 |
| Caris MPI, Inc. | $90.81 | 2 |
| Merck Sharp & Dohme Corporation | $68.45 | 3 |
| Astellas Pharma US Inc | $56.33 | 2 |
| Janssen Biotech, Inc. | $54.63 | 2 |
| Immunocore Limited | $53.76 | 2 |
| GlaxoSmithKline, LLC. | $49.66 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $38.86 | 2 |
| SOBI, INC | $32.92 | 1 |
| Celgene Corporation | $30.06 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.51 | 1 |
| ABBVIE INC. | $28.69 | 1 |
| Nuvation Bio Inc. | $26.20 | 1 |
| ARRAY BIOPHARMA INC | $24.43 | 1 |
| Stemline Therapeutics Inc. | $22.79 | 1 |
| Daiichi Sankyo Inc. | $22.43 | 1 |
| Rigel Pharmaceuticals, Inc. | $20.77 | 1 |
| Incyte Corporation | $19.46 | 1 |
| Deciphera Pharmaceuticals Inc. | $18.55 | 1 |
| Exelixis Inc. | $17.85 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.48 | 1 |
| Pharmacosmos Therapeutics Inc. | $17.20 | 1 |
| Sumitomo Pharma America, Inc. | $16.67 | 1 |
| TerSera Therapeutics LLC | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (71)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.